Human Cysteine Cathepsins Degrade Immunoglobulin G In Vitro in a Predictable Manner
Open Access
- 29 September 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (19), 4843
- https://doi.org/10.3390/ijms20194843
Abstract
Cysteine cathepsins are critical components of the adaptive immune system involved in the generation of epitopes for presentation on human leukocyte antigen (HLA) molecules and have been implicated in degradation of autoantigens. Immunoglobulin variable regions with somatic mutations and random complementarity region 3 amino acid composition are inherently immunogenic. T cell reactivity towards immunoglobulin variable regions has been investigated in relation to specific diseases, as well as reactivity to therapeutic monoclonal antibodies. Yet, how the immunoglobulins, or the B cell receptors, are processed in endolysosomal compartments of professional antigen presenting cells has not been described in detail. Here we present in silico and in vitro experimental evidence suggesting that cysteine cathepsins S, L and B may have important roles in generating peptides fitting HLA class II molecules, capable of being presented to T cells, from monoclonal antibodies as well as from central nervous system proteins including a well described autoantigen. By combining neural net models with in vitro proteomics experiments, we further suggest how such degradation can be predicted, how it fits with available cellular models, and that it is immunoglobulin heavy chain variable family dependent. These findings are relevant for biotherapeutic drug design as well as to understand disease development. We also suggest how these tools can be improved, including improved machine learning methodology.Keywords
Funding Information
- Akershus Universitetssykehus (Internal strategic funds)
- Novartis (Unrestricted research award (Norway))
This publication has 71 references indexed in Scilit:
- Recognition of Higher Order Patterns in Proteins: Immunologic KernelsPLOS ONE, 2013
- Composition of the HLA‐DR‐associated human thymus peptidomeEuropean Journal of Immunology, 2013
- Disulfide Reduction in the Endocytic Pathway: Immunological Functions of Gamma-Interferon-Inducible Lysosomal Thiol ReductaseAntioxidants and Redox Signaling, 2011
- Peptides Presented by HLA-DR Molecules in Synovia of Patients with Rheumatoid Arthritis or Antibiotic-Refractory Lyme ArthritisMolecular & Cellular Proteomics, 2011
- An integrated approach to epitope analysis II: A system for proteomic-scale prediction of immunological characteristicsImmunome Research, 2010
- An integrated approach to epitope analysis I: Dimensional reduction, visualization and prediction of MHC binding using amino acid principal components and regression approachesImmunome Research, 2010
- BioGPS: an extensible and customizable portal for querying and organizing gene annotation resourcesGenome Biology, 2009
- Reducing risk, improving outcomes: Bioengineering less immunogenic protein therapeuticsClinical Immunology, 2009
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008
- Transcriptional response of human microglial cells to interferon-γGenes & Immunity, 2005